Reaktionsgleichung
[CH3:1][C:2]1[C:7]([NH:8][C:9](=[O:13])[CH2:10][CH2:11][CH3:12])=[CH:6][N:5]=[C:4]2[N:14]([CH2:20][C:21]3[CH:26]=[CH:25][C:24]([C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=4[S:33]([NH2:36])(=[O:35])=[O:34])=[CH:23][CH:22]=3)[C:15]([CH2:17][CH2:18][CH3:19])=[N:16][C:3]=12.[CH2:37]([O:41][C:42](Cl)=[O:43])[CH2:38][CH2:39][CH3:40].CO>CN(C)C1C=CN=CC=1.N1C=CC=CC=1>[CH3:1][C:2]1[C:7]([NH:8][C:9](=[O:13])[CH2:10][CH2:11][CH3:12])=[CH:6][N:5]=[C:4]2[N:14]([CH2:20][C:21]3[CH:22]=[CH:23][C:24]([C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][C:28]=4[S:33]([NH:36][C:42]([O:41][CH2:37][CH2:38][CH2:39][CH3:40])=[O:43])(=[O:35])=[O:34])=[CH:25][CH:26]=3)[C:15]([CH2:17][CH2:18][CH3:19])=[N:16][C:3]=12Komponenten
6
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
To a mixture of 7-methyl-2-propyl-3-[2'-(aminosulfonyl)[1,1']biphenyl-4-yl]methyl-6-[(1-oxobutyl)amino]-3H-imidazo[4, 5-b]pyridine (60 mg, 0.112 mmol) and 4-dimethyaminopyridine (41 mg) in pyridine (1.5 mL) was added n-butylchloroformate (0.071 mL, 0.56 mmol). After 14 h at r.t., MeOH (1 mL) was added and the mixture was concentrated, dissolved in CH2Cl2 (40 mL), washed with 5% aqueous citric acid (2×20 mL), concentrated, and purified (SiO2, (89:9:1CH2Cl2 /MeOH/NH4OH) to give the title compound as a solid.
Aufarbeitung
- concentrationthe mixture was concentrated
- dissolutiondissolved in CH2Cl2 (40 mL)
- washwashed with 5% aqueous citric acid (2×20 mL)
- concentrationconcentrated
- custompurified (SiO2, (89:9:1CH2Cl2 /MeOH/NH4OH)
Quellen und Nachweise
- ORD-Eintrag
- ord-c56aea7a579b4fcea9a8071a9a4a67e5
- Quelldatensatz
- uspto-grants-1995_05
- Patentnummer
- US05412097
Verknüpfte Notizen
Wird geladen…